The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke

摘要

Research on commensal microbiota and its contribution to health and disease is a new and very dynamically developing field of biology and medicine. Recent experimental and clinical investigations underscore the importance of gut microbiota in the pathogenesis and course of stroke. Importantly, microbiota may influence the outcome of cerebral ischemia by modulating central nervous system antigen-specific immune responses. In this review we summarize studies linking gut microbiota with physiological function and disorders of the central nervous system. Based on these insights we speculate about targeting the gut microbiome in order to treat stroke.Electronic supplementary materialThe online version of this article (doi:10.1007/s13311-016-0475-x) contains supplementary material, which is available to authorized users.